LYS006

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
97	潰瘍性大腸炎	5

97. 潰瘍性大腸炎

臨床試験数 : 2,630 / 薬物数 : 1,459 - (DrugBank : 265) / 標的遺伝子数 : 144 - 標的パスウェイ数 : 202

trials per page:

Showing 1 to 5 of 5 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2019-003113-34-SK (EUCTR)	29/06/2021	27/04/2021	Study of efficacy, safety and tolerability of LYS006in patients with mild to moderate ulcerative col ...	A randomized, multi-center, subject and investigator blinded, placebo controlled, parallel group stu ...	Mild to moderate ulcerative colitis MedDRA version: 20.0;Level: PT;Classification code 10009900;Term ...	Product Name: LYS006 Product Code: LYS006 INN or Proposed INN: not yet defined Other descriptive name: ...	Novartis Pharma AG	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	45	Phase 2	United States;Czechia;Hungary;Slovakia;Poland;Bulgaria;Russian Federation;Norway;Germany
2	EUCTR2019-003113-34-NO (EUCTR)	04/05/2020	21/01/2020	Ulcerative colitis	A randomized, multi-center, subject and investigator blinded, placebo controlled, parallel group stu ...	Mild to moderate ulcerative colitis MedDRA version: 20.0;Level: PT;Classification code 10009900;Term ...	Product Name: LYS006 Product Code: LYS006 INN or Proposed INN: not yet defined Other descriptive name: ...	Novartis Pharma AG	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	45	Phase 2	United States;Czechia;Hungary;Slovakia;Poland;Russian Federation;Bulgaria;Germany;Norway
3	EUCTR2019-003113-34-HU (EUCTR)	25/02/2020	09/01/2020	Study of efficacy, safety and tolerability of LYS006in patients with mild to moderate ulcerative col ...	A randomized, multi-center, subject and investigator blinded, placebo controlled, parallel group stu ...	Mild to moderate ulcerative colitis MedDRA version: 20.0;Level: PT;Classification code 10009900;Term ...	Product Name: LYS006 Product Code: LYS006 INN or Proposed INN: not yet defined Other descriptive name: ...	Novartis Pharma AG	NULL	Not Recruiting			Female: yes Male: yes	45	Phase 2	Czech Republic;Russian Federation;Hungary;Norway;United States;Poland;Slovakia;Bulgaria;Germany
4	EUCTR2019-003113-34-DE (EUCTR)	19/02/2020	08/11/2019	Ulcerative colitis	A randomized, multi-center, subject and investigator blinded, placebo controlled, parallel group stu ...	Mild to moderate ulcerative colitis MedDRA version: 20.0;Level: PT;Classification code 10009900;Term ...	Product Name: LYS006 Product Code: LYS006 INN or Proposed INN: not yet defined Other descriptive name: ...	Novartis Pharma AG	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	45	Phase 2	United States;Hungary;Czech Republic;Norway;Germany
5	NCT04074590 (ClinicalTrials.gov)	February 3, 2020	29/8/2019	Study of Efficacy, Safety, and Tolerability of LYS006, in Patients With Mild to Moderate Ulcerative ...	A Randomized, Multi-center, Subject and Investigator-blinded, Placebo-controlled, Parallel-group Stu ...	Colitis, Ulcerative	Drug: LYS006;Drug: Placebo	Novartis Pharmaceuticals	NULL	Completed	18 Years	75 Years	All	23	Phase 2	Bulgaria;Czechia;Germany;Poland;Russian Federation;Slovakia;Hungary;Norway;United Kingdom;United Sta ...

First Previous1Next Last